Apr 23, 2013
Benefits of new proprietary technology include improved and consistent drug absorption, reducing patient variability and, potentially, side effects
Apr 22, 2013
New proprietary technology can improve taste and stability; deliver sustained release characteristics
Apr 18, 2013
Company's scientists can develop new formulations or accept transfer of existing products
Apr 10, 2013
Unique pellet formulations help support therapeutic effectiveness of of active pharmaceutical ingredients
Apr 08, 2013
Gastric sleeve weight-loss surgery patients report satisfaction with lack of visible scars, recovery and...
Feb 21, 2013
Joe Kapitan, AIA, NCARB, will manage clients' projects from ideation to occupancy
Feb 20, 2013
OsoBio President Milton Boyer and other experts will examine industry's shortages
Feb 13, 2013
Dr. Michael DeHart develops solid-dose formulations for Phase I-III clinical trial materials
Feb 04, 2013
Joe Cobb, CPIP, will oversee the company's formulation development, potent handling capabilities
Jan 31, 2013
Joe Cascone will manage the company's manufacturing and other operations